261 related articles for article (PubMed ID: 38480544)
1. Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer.
Elango A; Nesam VD; Sukumar P; Lawrence I; Radhakrishnan A
Arch Microbiol; 2024 Mar; 206(4):156. PubMed ID: 38480544
[TBL] [Abstract][Full Text] [Related]
2. Butyrate's (a short-chain fatty acid) microbial synthesis, absorption, and preventive roles against colorectal and lung cancer.
Karim MR; Iqbal S; Mohammad S; Morshed MN; Haque MA; Mathiyalagan R; Yang DC; Kim YJ; Song JH; Yang DU
Arch Microbiol; 2024 Mar; 206(4):137. PubMed ID: 38436734
[TBL] [Abstract][Full Text] [Related]
3. Butyrate generated by gut microbiota and its therapeutic role in metabolic syndrome.
Bridgeman SC; Northrop W; Melton PE; Ellison GC; Newsholme P; Mamotte CDS
Pharmacol Res; 2020 Oct; 160():105174. PubMed ID: 32860943
[TBL] [Abstract][Full Text] [Related]
4. The metabolite butyrate produced by gut microbiota inhibits cachexia-associated skeletal muscle atrophy by regulating intestinal barrier function and macrophage polarization.
Liu H; Xi Q; Tan S; Qu Y; Meng Q; Zhang Y; Cheng Y; Wu G
Int Immunopharmacol; 2023 Nov; 124(Pt B):111001. PubMed ID: 37804658
[TBL] [Abstract][Full Text] [Related]
5. Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.
Kibbie JJ; Dillon SM; Thompson TA; Purba CM; McCarter MD; Wilson CC
Immunobiology; 2021 Sep; 226(5):152126. PubMed ID: 34365090
[TBL] [Abstract][Full Text] [Related]
6. Butyrate's role in human health and the current progress towards its clinical application to treat gastrointestinal disease.
Hodgkinson K; El Abbar F; Dobranowski P; Manoogian J; Butcher J; Figeys D; Mack D; Stintzi A
Clin Nutr; 2023 Feb; 42(2):61-75. PubMed ID: 36502573
[TBL] [Abstract][Full Text] [Related]
7. Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models.
Panebianco C; Villani A; Pisati F; Orsenigo F; Ulaszewska M; Latiano TP; Potenza A; Andolfo A; Terracciano F; Tripodo C; Perri F; Pazienza V
Biomed Pharmacother; 2022 Jul; 151():113163. PubMed ID: 35617803
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers.
Son MY; Cho HS
J Microbiol Biotechnol; 2023 Jul; 33(7):849-856. PubMed ID: 37100764
[TBL] [Abstract][Full Text] [Related]
9. Butyrate suppresses motility of colorectal cancer cells via deactivating Akt/ERK signaling in histone deacetylase dependent manner.
Li Q; Ding C; Meng T; Lu W; Liu W; Hao H; Cao L
J Pharmacol Sci; 2017 Dec; 135(4):148-155. PubMed ID: 29233468
[TBL] [Abstract][Full Text] [Related]
10. Butyrate: More Than a Short Chain Fatty Acid.
Mohamed Elfadil O; Mundi MS; Abdelmagid MG; Patel A; Patel N; Martindale R
Curr Nutr Rep; 2023 Jun; 12(2):255-262. PubMed ID: 36763294
[TBL] [Abstract][Full Text] [Related]
11. Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways.
Chen J; Zhao KN; Vitetta L
Nutrients; 2019 May; 11(5):. PubMed ID: 31067776
[TBL] [Abstract][Full Text] [Related]
12. Butyrate: A Double-Edged Sword for Health?
Liu H; Wang J; He T; Becker S; Zhang G; Li D; Ma X
Adv Nutr; 2018 Jan; 9(1):21-29. PubMed ID: 29438462
[TBL] [Abstract][Full Text] [Related]
13. Butyrate Levels in the Transition from an Infant- to an Adult-Like Gut Microbiota Correlate with Bacterial Networks Associated with
Nilsen M; Madelen Saunders C; Leena Angell I; Arntzen MØ; Lødrup Carlsen KC; Carlsen KH; Haugen G; Hagen LH; Carlsen MH; Hedlin G; Jonassen CM; Nordlund B; Rehbinder EM; Skjerven HO; Snipen L; Staff AC; Vettukattil R; Rudi K
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33105702
[TBL] [Abstract][Full Text] [Related]
14. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?
Stilling RM; van de Wouw M; Clarke G; Stanton C; Dinan TG; Cryan JF
Neurochem Int; 2016 Oct; 99():110-132. PubMed ID: 27346602
[TBL] [Abstract][Full Text] [Related]
15. Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion.
Zhuang M; Shang W; Ma Q; Strappe P; Zhou Z
Mol Nutr Food Res; 2019 Dec; 63(23):e1801187. PubMed ID: 31556210
[TBL] [Abstract][Full Text] [Related]
16. The Role of Gut Microbiome-Derived Short-Chain Fatty Acid Butyrate in Hepatobiliary Diseases.
Pant K; Venugopal SK; Lorenzo Pisarello MJ; Gradilone SA
Am J Pathol; 2023 Oct; 193(10):1455-1467. PubMed ID: 37422149
[TBL] [Abstract][Full Text] [Related]
17. Effect of Cucumis melo L. peel extract supplemented postbiotics on reprograming gut microbiota and sarcopenia in hindlimb-immobilized mice.
Han S; Seo KH; Gyu Lee H; Kim H
Food Res Int; 2023 Nov; 173(Pt 2):113476. PubMed ID: 37803799
[TBL] [Abstract][Full Text] [Related]
18. The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.
Kaźmierczak-Siedlecka K; Stachowska E; Folwarski M; Przewłócka K; Makarewicz W; Bryl E
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7275-7284. PubMed ID: 34919227
[TBL] [Abstract][Full Text] [Related]
19. Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease.
Salvi PS; Cowles RA
Cells; 2021 Jul; 10(7):. PubMed ID: 34359944
[TBL] [Abstract][Full Text] [Related]
20. Butyrate in Energy Metabolism: There Is Still More to Learn.
Zhang L; Liu C; Jiang Q; Yin Y
Trends Endocrinol Metab; 2021 Mar; 32(3):159-169. PubMed ID: 33461886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
